XML 66 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Other Financial Information (Tables)
 12 Months Ended
Dec. 31, 2022
Other Financial Information [Abstract]  
Schedule of Components of Inventories, Current
The following summarizes the components of Inventories:
As of December 31,
(MILLIONS)20222021
Finished goods$2,603 $3,641 
Work-in-process5,519 4,424 
Raw materials and supplies859 994 
Inventories(a)
$8,981 $9,059 
Noncurrent inventories not included above(b)
$5,827 $939 
(a)The decrease from December 31, 2021 reflects lower levels of Comirnaty, partially offset by new products acquired through recent acquisitions and higher Paxlovid inventory levels.
(b)Included in Other noncurrent assets. The increase from December 31, 2021 is primarily due to strategic inventory build related to Paxlovid. Based on our current estimates and assumptions, there are no recoverability issues for these amounts.
Schedule of Component of Inventories, Noncurrent
The following summarizes the components of Inventories:
As of December 31,
(MILLIONS)20222021
Finished goods$2,603 $3,641 
Work-in-process5,519 4,424 
Raw materials and supplies859 994 
Inventories(a)
$8,981 $9,059 
Noncurrent inventories not included above(b)
$5,827 $939 
(a)The decrease from December 31, 2021 reflects lower levels of Comirnaty, partially offset by new products acquired through recent acquisitions and higher Paxlovid inventory levels.
(b)Included in Other noncurrent assets. The increase from December 31, 2021 is primarily due to strategic inventory build related to Paxlovid. Based on our current estimates and assumptions, there are no recoverability issues for these amounts.